These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6781007)

  • 21. Failure of anticholinergic drugs to antagonize the increase in dopamine seen after gammahydroxybutyric acid and axotomy.
    Stock G
    J Neural Transm; 1979; 44(1-2):137-43. PubMed ID: 438801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine.
    Hvizdos AJ; Bennett JA; Wells BG; Rappaport KB; Mendel SA
    Clin Pharm; 1983; 2(2):174-8. PubMed ID: 6883947
    [No Abstract]   [Full Text] [Related]  

  • 23. Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: a potential treatment for extrapyramidal syndromes.
    González-Lugo OE; Ceballos-Huerta F; Jiménez-Capdeville ME; Arankowsky-Sandoval G; Góngora-Alfaro JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1465-71. PubMed ID: 20713114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine.
    Church WH; Justice JB; Byrd LD
    Eur J Pharmacol; 1987 Jul; 139(3):345-8. PubMed ID: 3666010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haloperidol-induced disruption of conditioned avoidance responding: attenuation by prior training or by anticholinergic drugs.
    Fibiger HC; Zis AP; Phillips AG
    Eur J Pharmacol; 1975 Feb; 30(2):309-14. PubMed ID: 1126366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter: The effect of benztropine mesylate on plasma levels of butaperazine maleate.
    el-Yousef MK; Manier DH
    Am J Psychiatry; 1974 Apr; 131(4):471-2. PubMed ID: 4149998
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivo effects of benztropine and nomifensine on dopamine and noradrenaline terminals in rat brain.
    Broch OJ
    Eur J Pharmacol; 1979 Oct; 58(4):419-24. PubMed ID: 510376
    [No Abstract]   [Full Text] [Related]  

  • 28. Psychoactive properties of benztropine and trihexyphenidyl.
    Wilcox JA
    J Psychoactive Drugs; 1983; 15(4):319-21. PubMed ID: 6655530
    [No Abstract]   [Full Text] [Related]  

  • 29. Actions of trihexyphenidyl and benztropine on squid axon membranes.
    Wu CH; Narahashi T
    J Pharmacol Exp Ther; 1976 Apr; 197(1):135-41. PubMed ID: 1263127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal prolactin responses in tardive dyskinesia.
    Asnis GM; Sachar EJ; Langer G; Halpern FS; Fink M
    Psychopharmacology (Berl); 1979; 66(3):247-50. PubMed ID: 43550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures.
    Gardos G; Cole JO; Rapkin RM; LaBrie RA; Baquelod E; Moore P; Sovner R; Doyle J
    Arch Gen Psychiatry; 1984 Nov; 41(11):1030-5. PubMed ID: 6149737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a cholinergic role in haloperidol-induced catalepsy.
    Klemm WR
    Psychopharmacology (Berl); 1985; 85(2):139-42. PubMed ID: 3925479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin increases the activity of tuberoinfundibular and nigroneostriatal dopamine neurons: prolactin antiserum inhibits the haloperidol-induced increases in dopamine synthesis rates in median eminence and striatum of rats.
    Van Loon GR; Shum A; George SR; Shin SH
    Brain Res Bull; 1983 Apr; 10(4):539-45. PubMed ID: 6860978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive changes in the acute dyskinetic syndrome as a function of repeated elicitation in squirrel monkeys.
    Neale R; Gerhardt S; Fallon S; Liebman JM
    Psychopharmacology (Berl); 1982; 77(3):223-8. PubMed ID: 6126906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic reversal with benxtropine in schizophrenics. Practical and theoretical significance.
    Singh MM; Kay SR
    J Nerv Ment Dis; 1975 Apr; 160(4):258-66. PubMed ID: 1097596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protracted vomiting following abrupt cessation of psychotropics: a case report.
    Kalman T; Warner GM
    Can Psychiatr Assoc J; 1978 Apr; 23(3):163-5. PubMed ID: 647615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of benztropine and pargyline on the response of cat carotid chemoreceptors to sodium cyanide, acetylcholine and dopamine [proceedings].
    Docherty RJ
    J Physiol; 1979 Jul; 292(Suppl):53P. PubMed ID: 490388
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term application of haloperidol: effect of anticholinergic treatment on the rate of dopamine synthesis.
    Stock G; Kummer P; Steinbrenner J
    Adv Biochem Psychopharmacol; 1980; 24():291-4. PubMed ID: 6773302
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double-blind trial.
    Goff DC; Arana GW; Greenblatt DJ; Dupont R; Ornsteen M; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 1991 Apr; 11(2):106-12. PubMed ID: 2056136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.
    Crook JM; Tomaskovic-Crook E; Copolov DL; Dean B
    Am J Psychiatry; 2001 Jun; 158(6):918-25. PubMed ID: 11384900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.